Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeteo Biomedical develops and commercializes advanced drug/device combination product technologies focused on patient-centric delivery systems for pharmaceuticals and biologics. Their patented platforms—ZTECH-L™ and ZTECH-P™—enable precise metered-dose administration via nasal, ophthalmic, sublingual/buccal routes in both single-use and multi-dose formats. The company’s devices are used by pharma/biotech partners to deliver vaccines or therapeutics targeting infectious disease threats (including pandemic response), neurological conditions such as seizures or neurodegeneration, autoimmune disease management and more. Recent patents further strengthen their global IP position in the US/EU.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeteo Biomedical.